Serum amyloid P component is the shiga toxin 2-neutralizing factor in human blood

被引:37
作者
Kimura, T
Tani, S
Matsumoto, Y
Takeda, T
机构
[1] Teijin Ltd, Teijin Inst Biomed Res, Hino, Tokyo 1918512, Japan
[2] Teijin Ltd, Pharmaceut Dev Dept 1, Chiyoda Ku, Tokyo 1008585, Japan
[3] Natl Childrens Med Res Ctr, Dept Infect Dis Res, Setagaya Ku, Tokyo 1548509, Japan
关键词
D O I
10.1074/jbc.M107819200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been suggested that some factor present in human plasma binds to Shiga toxin 2 (Stx2) and neutralizes it in vitro (Bitzan, M., Klemt, M., Steffens, R., and Muller-Wiefel, D. E. (1993) Infection 21, 140-145). This factor does not exist in other species (Caprioli, A., Luzzi, I., Seganti, L., Marchetti, M., Karmali, M., Clarke, I., and Boyd, B. (1994) Recent Ada. VTEC Infect. 353-356). Because analysis of this factor is important to understanding the pathology induced by Shiga toxin-producing Escherichia coli, we purified this factor from human plasma and identified it. Purification was carried out by serially subjecting human plasma to Con A-Sepharose, DEAF-Sepharose, hydroxyapatite, and gel-filtration high performance liquid chromatography (HPLC), using Stx2-neutralizing activity as the indicator. The gel-filtration HPLC fraction yielded a single band on SDS-polyacrylamide gel electrophoresis. Twenty N-terminal amino acid residues of this fraction were analyzed and found to correspond perfectly to human serum amyloid P component (HuSAP). Because commercially available HuSAP also showed Stx2 binding and neutralizing activity, we identified this factor as HuSAP.
引用
收藏
页码:41576 / 41579
页数:4
相关论文
共 36 条
[1]   ANTICYTOTOXIN-NEUTRALIZING ANTIBODIES IN IMMUNE GLOBULIN PREPARATIONS - POTENTIAL USE IN HEMOLYTIC-UREMIC SYNDROME [J].
ASHKENAZI, S ;
CLEARY, TG ;
LOPEZ, E ;
PICKERING, LK .
JOURNAL OF PEDIATRICS, 1988, 113 (06) :1008-1014
[2]   Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections [J].
Bell, BP ;
Griffin, PM ;
Lozano, P ;
Christie, DL ;
Kobayashi, JM ;
Tarr, PI .
PEDIATRICS, 1997, 100 (01) :art. no.-e12
[3]   Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity [J].
Bickerstaff, MCM ;
Botto, M ;
Hutchinson, WL ;
Herbert, J ;
Tennent, GA ;
Bybee, A ;
Mitchell, DA ;
Cook, HT ;
Butler, PJG ;
Walport, MJ ;
Pepys, MB .
NATURE MEDICINE, 1999, 5 (06) :694-697
[4]   DIFFERENCES IN VEROTOXIN NEUTRALIZING ACTIVITY OF THERAPEUTIC IMMUNOGLOBULINS AND SERA FROM HEALTHY CONTROLS [J].
BITZAN, M ;
KLEMT, M ;
STEFFENS, R ;
MULLERWIEFEL, DE .
INFECTION, 1993, 21 (03) :140-145
[5]   Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans [J].
Boerlin, P ;
McEwen, SA ;
Boerlin-Petzold, F ;
Wilson, JB ;
Johnson, RP ;
Gyles, CL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) :497-503
[6]   AMYLOID-P COMPONENT IS LOCATED ON ELASTIC FIBER MICROFIBRILS IN NORMAL HUMAN-TISSUE [J].
BREATHNACH, SM ;
MELROSE, SM ;
BHOGAL, B ;
DEBEER, FC ;
DYCK, RF ;
TENNENT, G ;
BLACK, MM ;
PEPYS, MB .
NATURE, 1981, 293 (5834) :652-654
[7]   PENTRAXIN-CHROMATIN INTERACTIONS - SERUM AMYLOID-P COMPONENT SPECIFICALLY DISPLACES H1-TYPE HISTONES AND SOLUBILIZES NATIVE LONG CHROMATIN [J].
BUTLER, PJG ;
TENNENT, GA ;
PEPYS, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :13-18
[8]   HEMOLYTIC-UREMIC SYNDROME AND VERO CYTOTOXIN-PRODUCING ESCHERICHIA-COLI INFECTION IN ITALY [J].
CAPRIOLI, A ;
LUZZI, I ;
ROSMINI, F ;
PASQUINI, P ;
CIRRINCIONE, R ;
GIANVITI, A ;
MATTEUCCI, MC ;
RIZZONI, G .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) :154-158
[9]  
CAPRIOLI A, 1994, INT CONGR SER, V1072, P353
[10]  
CORIA F, 1988, LAB INVEST, V58, P454